{"id":"W4308405423","doi":"10.1016/s0140-6736(22)02034-7","title":"Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial","year":2022,"lang":"en","type":"article","venue":"The Lancet","topic":"Nitric Oxide and Endothelin Effects","field":"Medicine","cited_by":227,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Janssen Biotech; Idorsia Pharmaceuticals; Bausch Health; Menarini Group; Servier; Gedeon Richter; Amgen; High Blood Pressure Research Council of Australia; Novo Nordisk; Teva Pharmaceutical Industries; ReCor Medical; International Society of Hypertension; Ionis Pharmaceuticals; FibroGen; Alnylam Pharmaceuticals; AstraZeneca; Bristol-Myers Squibb; Abbott Laboratories","keywords":"Medicine; Placebo; Blood pressure; Ambulatory blood pressure; Diuretic; Clinical endpoint; Endothelin receptor antagonist; Internal medicine; Randomized controlled trial; Endothelin receptor","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002738275,0.00241369,0.004916467,0.0004680101,0.0005868546,0.0016989,0.001041442,0.002560436,0.00723032],"category_scores_gemma":[0.002460431,0.0009427714,0.003435292,0.0004784359,0.001521085,0.001459002,0.000618602,0.003530939,0.001195428],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008868547,"about_ca_system_score_gemma":0.001592659,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001345742,"about_ca_topic_score_gemma":0.002656744,"domain_scores_codex":[0.9989589,0.0004472239,0.00006607526,0.0002461291,0.00009536922,0.0001862089],"domain_scores_gemma":[0.9989445,0.0003264316,0.0002417041,0.0001366984,0.00008077308,0.0002699406],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9885939,0.001294406,0.000176124,0.0005524784,0.0010808,0.0000254265,0.00003012959,0.0001325726,0.001487571,0.00009522966,0.0005592329,0.005972113],"study_design_scores_gemma":[0.9894412,0.009590814,0.0003321445,0.00001487803,0.0002904816,0.00001089695,0.00000451392,0.00005194433,0.00005605326,0.00006395895,0.0001360354,0.000007050498],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.965686,0.01587265,0.003003994,0.001510016,0.002091204,0.005823783,0.002221368,0.0004304876,0.003360484],"genre_scores_gemma":[0.9654173,0.006641666,0.005904125,0.00320967,0.001424896,0.008552094,0.002044631,0.000079513,0.006726146],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00723032,"threshold_uncertainty_score":0.0241878,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06100171892594759,"score_gpt":0.3257877469879694,"score_spread":0.2647860280620218,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}